MiroBio continues expansion of executive leadership team

People

Mar 8

Written By Frances Benson

https://www.mirobio.com/news/

2022

Frances Benson

Nimbus Therapeutics presents clinical data from Ph1 study of oral allosteric TYK2 inhibitor at AAD Annual Meeting

BioTheryX appoints Nancy Miller- Rich as Board Chair